Newsroom

Epidermolysis Bullosa News - 12 September 2018

AMRYT’S AP101 FOR TREATING EB RECEIVES IND CLEARANCE FROM FDA

Read full article

Pharmafield - 10 September 2018

AMRYT OPENS US CLINICAL TRIALS FOR EPIDERMOLYSIS BULLOSA DRUG

Read full article

Pharmaceutical Executive - 10 September 2018

UK'S AMRYT TO OPEN US CLINICAL TRIAL SITES FOR EPIDERMOLYSIS BULLOSA

Read full article

The Irish Times - 10 September 2018

AMRYT SKIN THERAPY TRIAL GETS GREEN LIGHT IN US

Read full article

Pink Sheet - 03 September 2018

AMRYT ON TARGETING RARE DISEASE SPACE IN THE MIDDLE EAST

Subscription required to access article

Epidermolysis Bullosa News - 06 August 2018

AMRYT’S AP101 GRANTED RARE PEDIATRIC DISEASE DESIGNATION FOR EB

Read full article

Pharmafield - 03 August 2018

EPIDERMOLYSIS BULLOSA DRUG GIVEN RARE PAEDIATRIC DISEASE DESIGNATION

Read full article

The Irish Times - 02 August 2018

AMRYT PHARMA WINS KEY US DRUG DESIGNATION

Read full article

The Pharma Letter - 02 August 2018

RARE PEDIATRIC DISEASE DESIGNATION FOR AMRYT’S AP101

Read full article

Pharmafield - 19 July 2018

AMRYT PROVIDES AN UPDATE ON TRADING SUCCESS

Read full article

Pharmaphorum - 18 July 2018

NHS ENGLAND OKAYS FUNDING FOR CHOLESTEROL-LOWERING DRUG

Read full article

Pharmafield - 14 July 2018

NHS ENGLAND APPROVES LOJUXTA FUNDING FOR HOFH

Read full article

Pharmaceutical Business Review - 10 July 2018

AMRYT SECURES FUNDING APPROVAL FROM NHS ENGLAND FOR BAD CHOLESTEROL TREATMENT

Read full article

Pharmaphorum - 09 July 2018

NHS ENGLAND OKAYS FUNDING FOR CHOLESTEROL-LOWERING DRUG

Read full article

Pharma Times - 09 July 2018

NHS ENGLAND CLEARS SPECIALISED TREATMENTS FOR NHS USE

Read full article

Irish Independent - 09 July 2018

NHS APPROVE FUNDING FOR IRISH COMPANY’S BAD CHOLESTEROL TREATMENT

Read full article

Irish Times - 09 July 2018

AMRYT PHARMA HEART DRUG WINS APPROVAL FROM NHS ENGLAND

Read full article

Pharmaceutical Executive - 19 June 2018

AMRYT PHARMA: REALIZING RARE DISEASE TREATMENTS

Read full article

Daily Mirror - 06 June 2018

BRAVE WOMAN BORN A 'BUTTERFLY' CHILD REVEALS HORRIFIC REALITY OF CONDITION FROM NO FINGERPRINTS OR SKIN ON BACK TO CONSTANT 'BUBBLE WRAP' BLISTERS

Read full article

PharmaField Magazine - June 2018

Novel Gene Therapy Shows Promise

Read full article

Pink Sheet - 12 April 2018

Amryt On Navigating Orphan Pricing And Reimbursement

Subscription required to access article

Business Vision - 23 March 2018

Sweet gene victory around the corner? Therapeutic advances come rolling in

Read full article

Pharmaceutical Field - 21 March 2018

AMRYT ANNOUNCES A NEW PLATFORM TECHNOLOGY FOR GENE THERAPY

Read full article

Biocentry - 16 March 2018

AMRYT GETS EXCLUSIVE LICENSE TO GENE THERAPY PLATFORM

Subscription required to access article

Pharma Times - 16 March 2018

AMRYT IN-LICENSES NOVEL GENE THERAPY PLATFORM FROM UCD

Read full article

Pharmafile - 15 March 2018

The need for flexible appraisal of rare disease medicines

Read full article

PMLiVE - 06 March 2018

AMRYT PHARMA APPOINTS JORDI CASALS AS HEAD OF EUROPE

Read full article

Pharma Times - 06 March 2018

AMRYT PHARMA APPOINTS JORDI CASALS AS HEAD OF EUROPE

Read full article

The Pharma Letter - 06 March 2018

New distribution deal for Amryt’s Lojuxta

Read full article

PMLiVE - 01 February 2018

AMRYT PHARMA APPOINTS NEW REGULATORY AFFAIRS HEAD

Read full article

City A.M. - 24 January 2018

CITY MOVES FOR 25 JANUARY 2018

Read full article

APM Health Europe - 10 January 2018

AMRYT SIGNS DEAL TO BRING LOJUXTA BACK TO MARKET IN EUROPE FOR RARE CHOLESTEROL CONDITION

Subscription required to access article